Delivery Order SPE2DB22D9316-SPE2DB25FYP90
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of Botox 200 unit vials. The contract, valued at $5,508.60, has an ultimate completion date of April 10, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler based in Park Ridge, Illinois, that specializes in providing a comprehensive range of pharmaceutical products and medical supplies to federal government...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler located in Park Ridge, Illinois. The contract, valued at $44,087.00, is to provide BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DLA and DMS Pharmaceutical Group,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $34,611.00, is for the delivery of BOTOX 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the...
- The Defense Logistics Agency awarded a delivery order valued at $6,468.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and carries no set-aside designation. This award is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 Unit Vials. This firm fixed-price delivery order, issued on August 19, 2025, with an ultimate completion date of September 10, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA under the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $5,537.76 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Botox 100 unit vials to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $2,587.40 to DMS Pharmaceutical Group Inc. for the supply of Botox 200 unit vials. The award, issued on August 18, 2025, with an ultimate completion date of September 9, 2025, represents a standard procurement with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the delivery at its facility in Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $2,768.88, is for the delivery of 100-unit vials of Botox to fulfill the recurring pharmaceutical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,229.60 contract is for the supply of BOTOX 100 unit vials to support the recurring medical needs of military health facilities. This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between the DLA and DMS Pharmaceutical Group valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. This firm fixed-price delivery order, valued at $2,587.40, was awarded on August 13, 2025, with an ultimate completion date of September 4, 2025. The contract carries no set-aside designation, and performance will take place at the vendor's Park Ridge facility. This delivery...
- SPE2DB22D9316Indefinite Delivery Contract
- SPE2DB22D9316-SPE2DB25FYP90Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Botox 200 unit vials. The contract, valued at $32,342.50 with a firm fixed price structure, was awarded on August 28, 2025, with an ultimate completion date of September 19, 2025. No set-aside designation was applied to this procurement. This delivery order falls under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.99 billion vehicle through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide. DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal agencies and Department of Defense healthcare systems. The company has established itself as a significant supplier within the federal pharmaceutical supply chain through its extensive portfolio of contract awards covering various pharmaceutical products from oncology treatments to specialty injections. This Botox delivery order represents a continuation of the company's role as a critical pharmaceutical distributor, providing direct supply of medical products to support DoD healthcare operations domestically and internationally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $32.3k | 8/28/25 |